Colorectal cancer (CRC) is a major public health problem worldwide. CRC is the third most commonly diagnosed cancer in males, following prostate and lung cancer, which includes 10.9% of new cancer cases, and it is the second most commonly diagnosed cancer in females after breast cancer, including 9.5% of new cancer cases. Totally, it is the second cause of cancer-related deaths (about 9.2% in 2018) (
1,
2). The incidence rate of CRC was over 9% of all cancer incidence rates in 2012 with an estimated 1.4 million cases and 700,000 deaths worldwide (
3,
4). A substantial global burden is imposed by CRC due to its complications, mortality, side effects of treatment, utilization of healthcare services, and medical costs (
5). There are wide geographical variations in CRC incidence and mortality rates and socioeconomic status has a considerable proportion of these variations (
4). A common index to measure social and economic achievement of a country is the human development index (HDI) which combines three important indicators: life expectancy, education, and per capita income (
6). Various studies have revealed that the incidence and mortality of CRC have a significant increase in locations (e.g., countries) with medium and high HDI so that in 2012, 55% of CRC cases were related to the highly developed countries. Comparing age-standardized incidence rates, the highest rates have occurred in Australia and New Zealand, and the lowest have occurred in the countries of West Africa (
1,
3,
7). Although CRC is more prevalent in developed countries, its incidence rate has an increasing trend in developing regions such as Western Asia (Kuwait) and Eastern Europe (Czech Republic, Slovakia, and Slovenia) (
4). According to the literature, the increase in cancer incidence rate has been paralleled by the increase in the HDI in Iran as a developing country (
8-
11).